Related Experiment Video
Updated: Sep 27, 2026

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein
Published on: January 13, 2026
Catheter-Associated Soft Tissue Infection Caused by Pantoea piersonii in a Totally Implantable Venous Access Port:
Yachun Zhou1, Anmin Ren2, Xianting Huang2
1Department of Laboratory Medicine, Shenzhen University General Hospital, Shenzhen 518000, China.
Abstract:
Pantoea piersonii (formerly Kalamiella piersonii) is a recently reclassified environmental Gram-negative bacterium belonging to the family Erwiniaceae. Human infections caused by this organism are extremely rare. Here, we report a rare case of implantable venous access port-associated soft tissue infection caused by P. piersonii in a 49-year-old immunocompromised woman with lung cancer. The pathogen was isolated from purulent discharge obtained from the port site and identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Whole-genome sequencing confirmed species-level identification based on average nucleotide identity (ANI) analysis and phylogenomic reconstruction. The isolate exhibited broad antimicrobial susceptibility to the tested agents. Following complete device removal and empirical antimicrobial therapy, the patient recovered uneventfully. This study reports the first documented case of P. piersonii infection in China and provides a comprehensive clinical and genomic characterization of a newly isolated clinical strain.
Related Concept Videos
Endocarditis IV: Nursing Management
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Acute Pyelonephritis I: Introduction
